© Reuters. The logo of Chinese gene firm BGI Group is seen at its building in Beijing, China March 25, 2021. Picture taken March 25, 2021. REUTERS/Carlos Garcia Rawlins/File Photo
(Reuters) – The U.S. Senate’s homeland security committee voted on Wednesday to move forward a bill that could restrict business with Chinese biotech companies like BGI and WuXi Apptec on national security grounds.